SHC · XBRL financial data

Sotera Health Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	310*	248	277	285	290*	255	294	311	303*	280	321	325
Cost of revenue	130*	121	124	127	126*	119	128	134	138*	133	143	144
Gross profit	180*	127	153	158	164*	135	167	178	166*	147	178	181
Selling, general and administrative	60*	58	61	62	62*	63	69	63	58*	68	68	64
Total operating expenses	76*	74	76	78	77*	—	—	—	—	—	—	—
Operating income (loss)	104*	53	77	81	87*	—	—	—	—	—	—	—
Other income (expense)	4*	(1)	2	3	1*	0	6	0	2*	1	3	3
Income tax expense (benefit)	27*	5	6	26	33*	(2)	11	25	36*	16	24	25
Net income (loss)	39*	—	9	17	12*	(13)	8	48	35*	27	54	58
Earnings per share, basic USD per share	0.14*	0.02	0.03	0.06	0.04*	(0.05)	0.03	0.17	0.12*	0.09	0.19	0.20
Earnings per share, diluted USD per share	0.14*	0.02	0.03	0.06	0.04*	(0.05)	0.03	0.17	0.12*	0.09	0.19	0.20
Weighted average shares, basic millions of shares	281*	282	283	283	283*	284	284	284	284*	285	286	286
Weighted average shares, diluted millions of shares	286*	284	285	286	285*	284	286	287	290*	288	288	289

Fiscal quarters (SHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	296	261	246	307	277	304	332	299	345	314	357	412
Accounts receivable	148	111	124	130	140	128	137	142	139	137	151	153
Inventory	48	51	58	54	49	61	60	50	54	57	56	50
Prepaid and other current assets	54	54	57	57	51	55	66	72	65	69	75	77
Total current assets	557	487	498	564	526	555	608	578	613	586	646	701
Right-of-use asset	24	23	24	29	28	27	32	34	33	33	31	29
Goodwill	1,111	1,103	1,098	1,105	1,081	1,084	1,105	1,099	1,103	1,098	1,091	1,091
Total assets	3,130	3,060	3,058	3,149	3,072	3,098	3,217	3,186	3,263	3,236	3,307	3,387
Accounts payable	71	62	64	71	55	70	64	61	78	77	101	80
Accrued liabilities	122	62	69	83	90	114	144	140	125	86	84	99
Current portion of long-term debt	5	5	11	15	15	15	15	14	14	14	14	14
Total current liabilities	231	152	170	196	191	226	246	242	250	208	231	224
Long-term debt	2,224	2,225	2,214	2,211	2,208	2,205	2,203	2,129	2,127	2,124	2,126	2,123
Lease liability, non-current	20	19	21	26	24	24	28	31	30	29	28	26
Total liabilities	2,687	2,630	2,635	2,679	2,667	2,683	2,705	2,636	2,657	2,613	2,641	2,654
Accumulated deficit	(654)	(648)	(639)	(622)	(610)	(623)	(615)	(567)	(532)	(506)	(452)	(393)
Total stockholders' equity	444	429	423	470	405	414	511	550	606	623	666	733
Total liabilities and equity	3,130	3,060	3,058	3,149	3,072	3,098	3,217	3,186	3,263	3,236	3,307	3,387
Common shares outstanding (cover page) millions of shares	283	283	283	283	283	284	284	284	284	285	285	286

Fiscal quarters (SHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	39*	—	9	17	12*	(13)	8	48	35*	27	54	58
Stock-based compensation	8*	9	10*	10*	8*	7	8*	8*	8*	14	7*	8*
Depreciation and amortization	year only	—	—	—	year only	—	—	—	year only	—	—	—
Net cash from operating activities	113*	10	61*	97*	56*	56	57*	71*	103*	29	88*	111*
Purchases of property and equipment	65*	35	42*	36*	66*	20	31*	36*	51*	46	46*	53*
Net cash from investing activities	(65)*	(35)	(42)*	(36)*	(66)*	(20)	(31)*	(33)*	(51)*	(45)	(43)*	(52)*
Proceeds from long-term debt	0*	0	2,259*	0*	0*	—	—	0*	0*	—	—	—
Repayments of long-term debt	1*	1	2,259*	0*	4*	4	4*	75*	4*	4	0*	4*
Net cash from financing activities	(4)*	(12)	(29)*	(3)*	(7)*	(8)	(7)*	(77)*	(8)*	(13)	(2)*	(2)*
Net change in cash	49*	(39)	(15)*	61*	(30)*	27	28*	(33)*	45*	(31)	41*	56*

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Sotera Health	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
Progyny	153	351	50*	76.7M	Q2 FY26 10-QJun 30, 2026
Acadia Healthcare Company	163	895	98*	93.0M	Q3 FY26 10-QSep 30, 2026
Concentra Group Holdings Parent	158	606	135*	127.5M	Q2 FY26 10-QJun 30, 2026
agilon health	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026
Park Dental Partners	24	66	4.7*	4.8M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.